Expand FBIO Menu
FBIO MENU

FBIO Latest Press Releases

-- March 31, 2026 --

Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights Globe Newswire 4:05 PM

-- March 30, 2026 --

Fortress Biotech's Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million Globe Newswire 4:05 PM

-- March 25, 2026 --

Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights Globe Newswire 4:01 PM

-- March 18, 2026 --

Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026 Globe Newswire 8:30 AM

-- February 23, 2026 --

UPDATE: Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million Globe Newswire 9:24 AM
Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million Globe Newswire 8:30 AM
Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease Globe Newswire 8:00 AM

-- January 13, 2026 --

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States Globe Newswire 7:45 AM

-- December 15, 2025 --

Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission Globe Newswire 8:00 AM

-- December 10, 2025 --

Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology Globe Newswire 8:30 AM

-- November 14, 2025 --

Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights Globe Newswire 8:30 AM

-- November 12, 2025 --

Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights Globe Newswire 4:01 PM
Market Data Delayed 15 Minutes